Patent details

EP4185318 Title: EXTENDED, HIGH DOSE VEGF ANTAGONIST REGIMENS FOR TREATMENT OF ANGIOGENIC EYE DISORDERS

Basic Information

Publication number:
EP4185318
PCT Application Number:
US2022029462
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP227287240
PCT Publication Number:
WO2022245739
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
EXTENDED, HIGH DOSE VEGF ANTAGONIST REGIMENS FOR TREATMENT OF ANGIOGENIC EYE DISORDERS
French Title of Invention:
RÉGIMES D'ANTAGONISTE DE VEGF À DOSE ÉLEVÉE ET ÉTENDU POUR LE TRAITEMENT DE TROUBLES OCULAIRES ANGIOGÉNIQUES
German Title of Invention:
VERLÄNGERTE, HOCHDOSIERTE VEGF-ANTAGONISTEN-SCHEMATA ZUR BEHANDLUNG VON ANGIOGENEN AUGENERKRANKUNGEN
SPC Number:

Dates

Filing date:
16/05/2022
Grant date:
03/09/2025
EP Publication Date:
31/05/2023
PCT Publication Date:
24/11/2022
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
03/09/2025
EP B1 Publication Date:
03/09/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
16/05/2042
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
27/08/2025
 
 

Name:
Bayer HealthCare LLC
Address:
100 Bayer Boulevard, Whippany, NJ 07981, United States (US)

Name:
Regeneron Pharmaceuticals, Inc.
Address:
777 Old Saw Mill River Road, Tarrytown, NY 10591, United States (US)

Agent

Name:
NLO
From:
10/09/2025
Address:
P.O. Box 29720, 2502 LS The Hague, Netherlands (NL)
To:

Inventor

1

Name:
CHU, Karen
Address:
United States (US)

2

Name:
DA SILVA LEAL, Sergio Casimiro
Address:
Switzerland (CH)

3

Name:
RITTENHOUSE, Kay D.
Address:
United States (US)

4

Name:
ASMUS, Friedrich
Address:
Germany (DE)

5

Name:
EISSING, Thomas
Address:
Germany (DE)

6

Name:
BERLINER, Alyson J.
Address:
United States (US)

7

Name:
VITTI, Robert L.
Address:
United States (US)

Priority

1

Priority Number:
202163189541 P
Priority Date:
17/05/2021
Priority Country:
United States (US)

2

Priority Number:
202163235398 P
Priority Date:
20/08/2021
Priority Country:
United States (US)

3

Priority Number:
202263297420 P
Priority Date:
07/01/2022
Priority Country:
United States (US)

4

Priority Number:
202263306315 P
Priority Date:
03/02/2022
Priority Country:
United States (US)

Classification

IPC classification:
A61K 38/17; A61P 27/02;

Publication

European Patent Bulletin

Issue number:
202536
Publication date:
03/09/2025
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
01/06/2026
Annual Fee Number:
5
Annual Fee Amount:
52 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
08/09/2025 Power Of Attorney 1
10/09/2025 Outgoing Correspondence 1